Mimedx (MDXG) Inventory (2010 - 2026)

Mimedx has disclosed Inventory across 17 years of filings, most recently posting $26.2 million for Q1 2026.

• Inventory for Q1 2026 came in at $26.2 million, up 8.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.2 million (up 8.97% YoY), and the FY2025 annual result was $25.3 million, up 6.44% from the prior year.
• Inventory came in at $26.2 million for Q1 2026 at Mimedx, up from $25.3 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $26.5 million in Q3 2025 to a low of $13.2 million in Q1 2022.
• The 5-year median for Inventory is $23.8 million (2024), against an average of $20.6 million.
• Across the five-year window, Inventory soared 66.84% in 2024 and dropped 1.57% in 2025, its largest moves.
• Mimedx's Inventory stood at $13.2 million in 2022, then jumped by 59.46% to $21.0 million in 2023, then advanced by 13.25% to $23.8 million in 2024, then climbed by 6.44% to $25.3 million in 2025, then climbed by 3.5% to $26.2 million in 2026.
• The last three Inventory figures came in at $26.2 million (Q1 2026), $25.3 million (Q4 2025), and $26.5 million (Q3 2025), per Business Quant data.